![Brandon Smith](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Brandon Smith
Direttore operativo presso
PROTHENA CORPORATION PLC
Patrimonio netto: 422 240 $ in data 31/07/2026
Profilo
Brandon S.
Smith is Chief Operating Officer at Prothena Corp.
Plc since 2021.
Formerly, Mr. Smith was Chief Operating Officer at Iconic Therapeutics, Inc. from 2017 to 2020, Senior VP and VP-Corporate Development & Strategy at Impax Laboratories LLC from 2012 to 2017, and Executive Director-Biosimilars Strategy at Amgen, Inc. from 2011 to 2012.
Education includes undergraduate studies at the University of Michigan and an MBA from McCombs School of Business.
Partecipazioni note in società pubbliche
| Società | Data | Numero di azioni | Valutazione | Data di valutazione |
|---|---|---|---|---|
| 28/07/2026 | 52.000 ( 0,1% ) | 422 240 $ | 31/07/2026 |
Posizioni attive di Brandon Smith
| Società | Posizione | Inizio |
|---|---|---|
| PROTHENA CORPORATION PLC | Direttore operativo | 29/09/2021 |
Precedenti posizioni note di Brandon Smith
| Società | Posizione | Fine |
|---|---|---|
Iconic Therapeutics, Inc.
 Iconic Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops immunoconjugate proteins intended to translate scientific insight into breakthrough medicines for serious diseases | Direttore operativo | 01/01/2020 |
Impax Laboratories LLC
 Impax Laboratories LLC Pharmaceuticals: MajorHealth Technology Engages in development, manufacture and commercialization of generic and branded prescription pharmaceutical products | Corporate Officer/Principal | 01/01/2017 |
| AMGEN INC. | Corporate Officer/Principal | 01/01/2012 |
Formazione di Brandon Smith
Esperienze
Posizioni ricoperte
Attive
Inattive
Società nel listino
Aziende private
Relazioni
68
Relazioni di 1° grado
6
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Aziende private | 6 |
|---|---|
Amgen, Inc.
 Amgen, Inc. BiotechnologyHealth Technology Discovers, develops, manufactures and delivers human therapeutics | Health Technology |
Impax Laboratories LLC
Impax Laboratories LLC Pharmaceuticals: MajorHealth Technology Engages in development, manufacture and commercialization of generic and branded prescription pharmaceutical products | Health Technology |
Iconic Therapeutics, Inc.
Iconic Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops immunoconjugate proteins intended to translate scientific insight into breakthrough medicines for serious diseases | Health Technology |
University of Michigan
 University of Michigan Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Prothena Corp. Plc
 Prothena Corp. Plc BiotechnologyHealth Technology Focuses on the discovery and development of novel antibodies | Health Technology |
McCombs School of Business
 McCombs School of Business Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
